Engineered Aptamer‐Derived Fluorescent Aptasensor: the Label‐Free, Single‐Step, Rapid Detection of Vancomycin in Clinical Samples
Small · 2025
DOI: 10.1002/smll.202407799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Zhou-Jie Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, …. Hauptthemen laut MEDLINE: Vancomycin, Aptamers, Nucleotide, Biosensing Techniques, Fluorescent Dyes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation of Science and Technology, Fujian Province, China.
Abstract (Originalsprache)
Currently, the reported vancomycin (VCM) aptamers, including the 3‐ ( K d = 9.13 × 10 −6 m ) and 4‐truncated variants ( K d = 45.5 × 10 −6 m ), are engineered via stem truncation of the VCM parent aptamer, which inevitably compromises their affinities, thus affecting their clinical application within the VCM therapeutic window of 6.9–13.8 × 10 −6 m . Herein, the binding pocket of the VCM parent aptamer is elucidated for the first time and we implemented the Post‐SELEX modification strategy involving truncation and mutagenesis to refined the VCM parent aptamer. This yielded a VCM aptamer (ABC20‐11) with an intramolecular G‐triplex, an enhanced thioflavin T (ThT) fluorescence intensity, and an improved affinity ( K d = 0.591 × 10 −6 m ) and specificity (one‐methyl level) for VCM. Utilizing a portable fluorescence detector specifically designed for rapidly detecting VCM concentration and leveraging the competitive binding between VCM and ThT to ABC20‐11, a label‐free fluorescent aptasensor is developed. This aptasensor exhibits exceptional analytical performances across various clinical samples (serum, cerebrospinal fluid, and joint fluid), with corresponding linear ranges of 0.5–50, 0.5–40, and 0.5–50 × 10 −6 m and detection limits at 0.11, 0.12, and 0.16 × 10 −6 m , respectively. Consequently, the proposed VCM aptasensor displays considerable clinical value and potential for use in rapid VCM detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
- The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
- Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Faculty of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
ORCID-Profile: Zhou-Jie Liu
Förderung
- National Natural Science Foundation of China
- Innovation of Science and Technology, Fujian Province, China
Zitieren
APA
Liu, Z. J., Liang, Y. Q., Li, J. Y., Wu, B., Huang, C., Liu, Y. W., Zhang, C. Z., Yang, Y., Cai, N. Q., Chen, J. Y., & Lin, X. H. (2025). Engineered Aptamer‐Derived Fluorescent Aptasensor: the Label‐Free, Single‐Step, Rapid Detection of Vancomycin in Clinical Samples. Small. https://doi.org/10.1002/smll.202407799
Vancouver
Liu ZJ, Liang YQ, Li JY, Wu B, Huang C, Liu YW, et al. Engineered Aptamer‐Derived Fluorescent Aptasensor: the Label‐Free, Single‐Step, Rapid Detection of Vancomycin in Clinical Samples. Small. 2025. doi:10.1002/smll.202407799
BibTeX
@article{Liu2025,
author = {Liu, Zhou-Jie and Liang, Yu-Qi and Li, Jia-Yi and Wu, Bing and Huang, Chen and Liu, Yi-Wei and Zhang, Chen-Zhi and Yang, Ye and Cai, Nai-Qing and Chen, Jin-Yuan and Lin, Xin-Hua},
title = {Engineered Aptamer‐Derived Fluorescent Aptasensor: the Label‐Free, Single‐Step, Rapid Detection of Vancomycin in Clinical Samples},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202407799}
}
EUVIMED